feed,title,long_url,short_url
SeekingAlpha,Ternium: Still Not A Buy As Near-Term Growth Prospects Remain Unfavorable,https://seekingalpha.com/article/4722181,
SeekingAlpha,"Edgewise: Stock Is Bouncing On Heart Disease Drug Data, Albeit From Just 7 Patients (Rating Upgrade)",https://seekingalpha.com/article/4722180,
